Grundinformationen
- Standard-SMILES
CCCC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1OC(=O)CCC- InChIKey
CJGYSWNGNKCJSB-YVLZZHOMSA-N- Summenformel
- C18H24N5O8P
- Durchschnittliche Molmasse
- 469,4 g/mol
- Monoisotopische Masse
- 469,13624974
Namen und Bezeichner
- Bevorzugter Name
- Bucladesine
- IUPAC
- [(4aR,6R,7R,7aR)-6-[6-(butanoylamino)purin-9-yl]-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl] butanoate
- Lokaler Name
- Bucladesin
- Englischer Name
- Bucladesine
- Summenformel
- C18H24N5O8P
- Molmasse
- 469.39
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
362-74-3- PubChem CID
- 9687
- DTXSID
DTXSID1040459- ChEMBL
CHEMBL485980- ChEBI
CHEBI:50095- UNII
- 63X7MBT2LQ
- EC Number
- 206-649-8
- Nikkaji
- J33.134A
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- -0,5
- Polarare Oberfläche (TPSA)
- 164 Ų
- H-Brücken-Donoren
- 2
- H-Brücken-Akzeptoren
- 11
- Frei drehbare Bindungen
- 8
- Schwere Atome
- 32
- Formalladung
- 0
- Komplexität
- 759
Experimentelle und physikochemische Eigenschaften
Collision Cross Section
215.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
210.36 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];214.52 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];214.45 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
Physikochemische Eigenschaften
- Dichte
- 1.72 · 1.72±0.1 g/cm3(Predicted)
- storage temp.
- -20 °C · -20°C Freezer
- Löslichkeit
- DMSO; Methano
- pka
- 0.82 · 0.82±0.60(Predicted)
- Aggregatzustand
- Solid
- Farbe
- White
Sicherheit und Regulatorisches
Gefahrenhinweise
Other Safety Information
IMAP assessments - Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate: Environment tier I assessment;IMAP assessments - Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate: Human health tier I assessment
Sicherheitsdaten
- Alarmwort
- Warnung
- Gefahrenhinweise
- Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H302
Chemie und Industrie
Pharmakologische Informationen
ATC Code
C - Cardiovascular system;C01 - Cardiac therapy;C01C - Cardiac stimulants excl. cardiac glycosides;C01CE - Phosphodiesterase inhibitors;C01CE04 - Bucladesine
QC - Cardiovascular system;QC01 - Cardiac therapy;QC01C - Cardiac stimulants excl. cardiac glycosides;QC01CE - Phosphodiesterase inhibitors;QC01CE04 - Bucladesine
Anwendungen
BeschreibungBucladesine is a cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed)
VerwendenBucladesine is a cell permeable cAMP analog. The compound is used in a wide variety of research applications because it mimics cAMP and can induce normal physiological responses when added to cells in experimental conditions. cAMP is only able to elicit minimal responses in these situations. The neurite outgrowth instigated by bucladesine in cell cultures has been shown to be enhanced by nardosinone.
Anbieter50 Anbieter
Ergänzende Hinweise
DefinitionChEBI: Bucladesine is a 3',5'-cyclic purine nucleotide that is the 2'-butanoate ester and 6-N-butanoyl derivative of 3',5'-cyclic AMP. It has a role as an agonist, a vasodilator agent and a cardiotonic drug. It is a butyrate ester, a 3',5'-cyclic purine nucleotide and a member of butanamides. It is functionally related to a 3',5'-cyclic AMP.
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…